Tiziana life sciences plc: court sanctions the scheme of arrangement and approves reduction of capital

London and new york, oct. 19, 2021 (globe newswire) -- tiziana life sciences plc (nasdaq: tlsa / lse: tils) ("old tiziana") a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases announced on 20 august 2021 that it had formally commenced its strategic plan to change its corporate structure by establishing tiziana life sciences ltd (“new tiziana”), a bermuda-incorporated company, as the ultimate parent company of the tiziana group. the reorganisation will be achieved by a scheme of arrangement under part 26 of the companies act 2006 (the "scheme").
TLSA Ratings Summary
TLSA Quant Ranking